Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―
Circulation Journal · 24.07.2026 · 90 (8) · 1055-1065
DOI: 10.1253/circj.cj-25-1114 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Circulation Journal, erschienen am 24.07.2026. Verfasst von Kenji Kanenawa und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kokura Memorial Hospital. Hauptthemen laut MEDLINE: Aspirin, Clopidogrel, Diabetes Mellitus, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Kokura Memorial Hospital.
- Department of Cardiovascular Medicine, Saga University.
- Department of Cardiology, Hirakata Kohsai Hospital.
- Department of Clinical Epidemiology, Hyogo College of Medicine.
- Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
- Department of Cardiology, Japanese Red Cross Wakayama Medical Center.
Zitieren
APA
Kanenawa, K., Yamamoto, K., Domei, T., Natsuaki, M., Watanabe, H., Morimoto, T., Obayashi, Y., Nishikawa, R., Kimura, T., Ando, K., Suwa, S., Isawa, T., Takenaka, H., Ishikawa, T., Yamada, M., Wakatsuki, T., Nozaki, Y., Kitahara, H., Kato, R., …, & STOPDAPT-3 Investigators (2026). Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―. Circulation Journal, 90(8), 1055-1065. https://doi.org/10.1253/circj.cj-25-1114
Vancouver
Kanenawa K, Yamamoto K, Domei T, Natsuaki M, Watanabe H, Morimoto T, et al. Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―. Circulation Journal. 2026;90(8):1055-1065. doi:10.1253/circj.cj-25-1114
BibTeX
@article{Kanenawa2026,
author = {Kanenawa, Kenji and Yamamoto, Ko and Domei, Takenori and Natsuaki, Masahiro and Watanabe, Hirotoshi and Morimoto, Takeshi and Obayashi, Yuki and Nishikawa, Ryusuke and Kimura, Tomoya and Ando, Kenji and Suwa, Satoru and Isawa, Tsuyoshi and Takenaka, Hiroyuki and Ishikawa, Tetsuya and Yamada, Minoru and Wakatsuki, Tetsuzo and Nozaki, Yoichi and Kitahara, Hideki and Kato, Ryuichi and Kawai, Ryoma and Kobayashi, Yohei and Ishii, Mitsuru and Goto, Yoshitaka and Ono, Koh and Kimura, Takeshi and STOPDAPT-3 Investigators, STOPDAPT-3 Investigators},
title = {Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―},
journal = {Circulation Journal},
year = {2026},
volume = {90},
number = {8},
pages = {1055--1065},
doi = {10.1253/circj.cj-25-1114}
}
EUVIMED